In Defense of Ecology

Raymond J. O'Connor1 attributes what he calls the "faltering progress of ecological research" to lack of creativity on the part of ecologists and a failure to follow the examples of more "successful" sciences (e.g., molecular genetics and physics). We agree that ecology would benefit from a greater emphasis on generality and conceptual unification. However, we take issue with both the contention that ecological science has failed to progress and that the approaches of other disciplines can be ap

Written byJonathan Shurin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Raymond J. O'Connor1 attributes what he calls the "faltering progress of ecological research" to lack of creativity on the part of ecologists and a failure to follow the examples of more "successful" sciences (e.g., molecular genetics and physics). We agree that ecology would benefit from a greater emphasis on generality and conceptual unification. However, we take issue with both the contention that ecological science has failed to progress and that the approaches of other disciplines can be applied to ecology to produce more worthwhile science.

O'Connor's evidence that ecology is unsuccessful takes three forms. First, he contends that ecological hypotheses are focused on natural history and not general hypotheses about how ecological systems work. He cites three ecological studies that employ "rigorous analysis and logical thinking" and contends that these examples are anachronistic. These studies very well represent the state of the art in ecology. Even a casual look at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies